SRGN and esophageal squamous cell carcinoma: Knockdown of MDK in SRGN-overexpressing cells not only reduced ESCC cell viability (Figure S8E) and invasion in vitro (Figure 6D andFigure S8F), but also suppressed lung metastasis in vivo to the same extent as SRGN-knockdown (Figure 6E).